Neogenomics (NEO) Change in Receivables (2010 - 2026)

Neogenomics (NEO) has 17 years of Change in Receivables data on file, last reported at $8.0 million in Q2 2026.

• Quarterly Change in Receivables rose 849.39% year-over-year to $8.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $22.7 million (up 538.17% YoY) and the FY2025 annual result came in at $6.2 million, down 68.01% from the prior year.
• Change in Receivables slipped to $8.0 million in Q2 2026, from $8.2 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $9.1 million in Q1 2024 to a low of -$1.4 million in Q4 2023.
• A 5-year average of $3.4 million and a median of $3.3 million in 2025 frame the typical range for Change in Receivables.
• The widest YoY moves for Change in Receivables: up 1271.46% in 2023, down 118.3% in 2023.
• Tracing NEO's Change in Receivables over 5 years: stood at $7.7 million in 2022, then sank by 118.3% to -$1.4 million in 2023, then surged by 37.11% to -$888000.0 in 2024, then jumped by 573.76% to $4.2 million in 2025, then jumped by 89.71% to $8.0 million in 2026.
• The last three Change in Receivables figures came in at $8.0 million (Q2 2026), $8.2 million (Q1 2026), and $4.2 million (Q4 2025), per Business Quant data.